TEMBEXA
Solicitation number 6D024-224321/A
Publication date
Closing date and time 2022/06/23 14:00 EDT
Last amendment date
Description
Trade Agreement: CETA/WTO-AGP/CPTPP/CFTA/FTAs with Peru/Colombia/Panama/Korea/UK Tendering Procedures: Generally only one firm has been invited to bid Non-Competitive Procurement Strategy: Exclusive Rights Comprehensive Land Claim Agreement: No Vendor Name and Address: Chimerix, Inc. 2505 Meridian Pkwy, Suite 100 Durham North Carolina United States 27713 Nature of Requirements: 1. Definition of the requirement Public Services and Procurement Canada intends to establish a Contract with Chimerix Inc. for Tembexa® (brincidofovir) which is an antiviral used to treat smallpox. 2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements) Any interested supplier must demonstrate by way of a statement of capabilities that it meets the following requirements: a) The product must have regulatory approval from one of the following: US FDA, EMA, UK MHRA, or Health Canada. b) The product must be have an indication for the treatment of human smallpox disease in adult and pediatric patients, including neonates. c) The product must be an orthopoxvirus nucleotide analog DNA polymerase inhibitor. d) All packaging of the product must be labelled in accordance with the direction of the approval regulatory agency. e) The product must be manufactured in accordance with current Good Manufacturing Practices. 3. Applicability of the trade agreement(s) to the procurement This requirement is subject to the Canadian Free Trade Agreement (CFTA), the Canada - Korea Free Trade Agreement, the Canada - Chile Free Trade Agreement (CCFTA), the Canada - Colombia Free Trade Agreement, the Canada - Honduras Free Trade Agreement, the Canada - Panama Free Trade Agreement, the Canada - Peru Free Trade Agreement (CPFTA), the Canada - Ukraine Free Trade Agreement (CUFTA),the Canada - European Union Comprehensive Economic and Trade Agreement (CETA), the Canada - United Kingdom Trade Continuity Agreement Canada-UK TCA) the Revised World Trade Organization Agreement on Government Procurement (WTO-AGP), and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). 4. Justification for the Pre-Identified Supplier This requirement is being negotiated with Chimerix Inc. as they are the only known supplier capable of providing an antiviral that is a nucleotide analog DNA polymerase inhibitor and also for treatment of smallpox in pediatric patients. The following exception(s) to the Government Contracts Regulations is invoked for this procurement under subsection 6(d) only one person is capable of performing the work. 5. Period of the Contract From contract award to until all deliverables are received. 6. Name and address of the pre-identified supplier Chimerix Inc. 2505 Meridian Parkway, Suite 100 Durham, North Carolina USA 27713 7. The closing date and time for accepting statements of capabilities is June 23, 2022 at 2:00pm. Delivery Date: Above-mentioned You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above. An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process. Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements. The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page. The Crown retains the right to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada.
Contract duration
Refer to the description above for full details.
Trade agreements
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Panama Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
-
Canada-Colombia Free Trade Agreement
-
Canada-Peru Free Trade Agreement (CPFTA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Contact information
Contracting organization
- Organization
-
Public Works and Government Services Canada
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Joy, Sharon
- Phone
- (613) 327-0456 ( )
- Email
- sharon.joy@tpsgc-pwgsc.gc.ca
- Address
-
Terrasses de la Chaudière 5th Floor
10 Wellington StreetGatineau, Quebec, K1A 0S5
Buying organization(s)
- Organization
-
Public Health Agency of Canada
- Address
-
130 Colonnade RoadOttawa, Ontario, K1A 0K9Canada
Bidding details
Details for this tender opportunity are provided in the Description tab.
Please contact the contracting officer to get the full solicitation documentation, access information on how to bid, or if you have any questions regarding this tender opportunity.
Note that there may be fees to access the documents or bid. These should be outlined in the Description tab.
We recommend that you contact the contracting officer as soon as possible, as there may be deadlines for receiving questions.